Euglycemic diabetic ketoacidosis: A review

Current Diabetes Reviews

Volumn 12, Issue , 2016, Pages

  Modi, Anar ^a   Agrawal, Abhinav ^b   Morgan, Farah ^a  

^a Department of Anesthesiology   (United States)

^b MONMOUTH MEDICAL CENTER   (United States)

Author keywords

Alcohol; Diabetic ketoacidosis; Euglycemia; Pregnancy; Pseudo normoglycemia; SGLT 2 inhibitors; Starvation

Indexed keywords

INSULIN; SODIUM GLUCOSE COTRANSPORTER 2 INHIBITOR; ALCOHOL; BICARBONATE; GLYCOGEN; SLC5A2 PROTEIN, HUMAN; SODIUM GLUCOSE COTRANSPORTER 2;

ALCOHOL CONSUMPTION; DIABETIC KETOACIDOSIS; DIABETIC PATIENT; EUGLYCEMIC DIABETIC KETOACIDOSIS; GLUCOSE BLOOD LEVEL; GLYCOGEN STORAGE DISEASE; HUMAN; INSULIN TREATMENT; PATHOGENESIS; PATHOPHYSIOLOGY; PREGNANCY; PRIORITY JOURNAL; REVIEW; STARVATION; BICARBONATE BLOOD LEVEL; BLOOD PH; CALORIC INTAKE; CHRONIC LIVER DISEASE; DIABETES MELLITUS; FEMALE; HYPERGLYCEMIA; METABOLIC ACIDOSIS; ANTAGONISTS AND INHIBITORS; BLOOD; DRINKING BEHAVIOR; PREGNANCY COMPLICATION;

ALCOHOL DRINKING; BLOOD GLUCOSE; DIABETIC KETOACIDOSIS; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; SODIUM-GLUCOSE TRANSPORTER 2; STARVATION;

EID: 84983548064     PISSN: 15733998     EISSN: 18756417     Source Type: Journal    
DOI: 10.2174/1573399812666160421121307     Document Type: Review

References (53)

1. Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes care 2009; 32: 1335-1343.
2. Nyenwe EA, Kitabchi AE. The evolution of diabetic ketoacidosis: An update of its etiology, pathogenesis and management. Metabolism: clinical and experimental 2016; 65: 507-521.
3. Malone ML, Gennis V, Goodwin JS. Characteristics of diabetic ketoacidosis in older versus younger adults. Journal of the American Geriatrics Society 1992; 40: 1100-1104.
4. Umpierrez G, Freire AX. Abdominal pain in patients with hyperglycemic crises. Journal of critical care 2002; 17: 63-67.
5. Eisenbarth GS PK, Buse JB. Type 1 diabetes mellitus: Acute diabetic emergencies: Diabetic ketoacidosis. In: Williams Textbook of Endocrinology. Philadelphia: Elsevier Science; 2003.
6. Nathan K, Agarwal A, Agrawal A, Park D. Euglycemic Diabetic Ketoacidosis: An Easily Missed Diagnosis. Chest 2015; 148(4-MeetingAbstracts): 255A.
7. Lebovitz HE. Diabetic ketoacidosis. Lancet 1995; 345: 767-772.
8. Munro JF, Campbell IW, McCuish AC, Duncan LJ. Euglycaemic diabetic ketoacidosis. British medical journal 1973; 2: 578-580.
9. Jenkins D, Close CF, Krentz AJ et al. Euglycaemic diabetic ketoacidosis: does it exist? Acta diabetologica 1993; 30: 251-253.
10. Davies RG, De P, Child DF et al. Euglycaemic diabetic ketoacidosis. Hospital medicine 2003; 64: 557-558.
11. Joseph F, Anderson L, Goenka N, Vora J. Starvation-induced true diabetic euglycemic ketoacidosis in severe depression. Journal of general internal medicine 2009; 24: 129-131.
12. Legaspi R, Narciso P. Euglycemic Diabetic Ketoacidosis Due to Gastroparesis, A Local Experience. J Ark Med Soc 2015; 112: 62-63.
13. Bas VN, Uytun S, Torun YA. Diabetic euglycemic ketoacidosis in newly diagnosed type 1 diabetes mellitus during Ramadan fasting. J Pediatr Endocrinol Metab 2015; 28: 333-335.
14. Burge MR, Hardy KJ, Schade DS. Short-term fasting is a mechanism for the development of euglycemic ketoacidosis during periods of insulin deficiency. J Clin Endocrinol Metab 1993; 76: 1192-1198.
15. Foster DW, McGarry JD. The metabolic derangements and treatment of diabetic ketoacidosis. The New England journal of medicine 1983; 309: 159-169.
16. Burge MR, Garcia N, Qualls CR, Schade DS. Differential effects of fasting and dehydration in the pathogenesis of diabetic ketoacidosis. Metabolism: clinical and experimental 2001; 50: 171-177.
17. Rothman DL, Magnusson I, Katz LD et al. Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR. Science 1991; 254: 573-576.
18. Jensen MD, Haymond MW, Gerich JE et al. Lipolysis during fasting. Decreased suppression by insulin and increased stimulation by epinephrine. The Journal of clinical investigation 1987; 79: 207-213.
19. Thawabi M, Studyvin S. Euglycemic Diabetic Ketoacidosis, a Misleading Presentation of Diabetic Ketoacidosis. North American journal of medical sciences 2015; 7: 291-294.
20. Jensen MD, Haymond MW, Rizza RA et al. Influence of body fat distribution on free fatty acid metabolism in obesity. The Journal of clinical investigation 1989; 83: 1168-1173.
21. Reichard GA, Jr., Owen OE, Haff AC et al. Ketone-body production and oxidation in fasting obese humans. The Journal of clinical investigation 1974; 53: 508-515.
22. Owen OE, Caprio S, Reichard GA, Jr. et al. Ketosis of starvation: a revisit and new perspectives. Clinics in endocrinology and metabolism 1983; 12: 359-379.
23. Cullen MT, Reece EA, Homko CJ, Sivan E. The changing presentations of diabetic ketoacidosis during pregnancy. American journal of perinatology 1996; 13: 449-451.
24. Montoro MN, Myers VP, Mestman JH et al. Outcome of pregnancy in diabetic ketoacidosis. American journal of perinatology 1993; 10: 17-20.
25. Brumfield CG, Huddleston JF. The management of diabetic ketoacidosis in pregnancy. Clinical obstetrics and gynecology 1984; 27: 50-59.
26. Carroll MA, Yeomans ER. Diabetic ketoacidosis in pregnancy. Critical care medicine 2005; 33: S347-353.
27. Chico M, Levine SN, Lewis DF. Normoglycemic diabetic ketoacidosis in pregnancy. Journal of perinatology: official journal of the California Perinatal Association 2008; 28: 310-312.
28. Metzger BE, Ravnikar V, Vileisis RA, Freinkel N. "Accelerated starvation" and the skipped breakfast in late normal pregnancy. Lancet 1982; 1: 588-592.
29. Tarif N, Al Badr W. Euglycemic diabetic ketoacidosis in pregnancy. Saudi journal of kidney diseases and transplantation: an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 2007; 18: 590-593.
30. Wrenn KD, Slovis CM, Minion GE, Rutkowski R. The syndrome of alcoholic ketoacidosis. The American journal of medicine 1991; 91: 119-128.
31. Pelli H, Lappalainen-Lehto R, Piironen A et al. Pancreatic damage after the first episode of acute alcoholic pancreatitis and its association with the later recurrence rate. Pancreatology: official journal of the International Association of Pancreatology 2009; 9: 245-251.
32. Prater J, Chaiban J. Euglycemic Diabetic Ketoacidosis with Acute Pancreatitis in a Patient Not Known to Have Diabetes. Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2014: 1-12.
33. Singh AK. Sodium-glucose co-transporter-2 inhibitors and euglycemic ketoacidosis: Wisdom of hindsight. Indian J Endocrinol Metab 2015; 19: 722-730.
34. Ogawa W, Sakaguchi K. Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors. Journal of diabetes investigation 2015: n/a-n/a.
35. Kibbey RG. SGLT-2 inhibition and glucagon: Cause for alarm? Trends in endocrinology and metabolism: TEM 2015; 26: 337-338.
36. FDA Drug Safety Communication: FDA revises labels of SGLT2 inhibitors for diabetes to include warnings about too much acid in the blood and serious urinary tract infections. In: 2015.
37. Rumbak MJ, Hughes TA, Kitabchi AE. Pseudonormoglycemia in diabetic ketoacidosis with elevated triglycerides. The American journal of emergency medicine 1991; 9: 61-63.
38. Nikolac N. Lipemia: causes, interference mechanisms, detection and management. Biochemia medica 2014; 24: 57-67.
39. Kaminska ES, Pourmotabbed G. Spurious laboratory values in diabetic ketoacidosis and hyperlipidemia. The American journal of emergency medicine 1993; 11: 77-80.
40. Akbay S, Yel A, Yildirimer U et al. Diabetic ketoacidosis presenting with pseudonormoglycemia in a 15-year-old girl with type 1 diabetes mellitus. Journal of clinical research in pediatric endocrinology 2013; 5: 133-135.
41. Melis D, Fulceri R, Parenti G et al. Genotype/phenotype correlation in glycogen storage disease type 1b: a multicentre study and review of the literature. Eur J Pediatr 2005; 164: 501-508.
42. Jenkins DW, Eckle RE, Craig JW. Alcoholic ketoacidosis. Jama 1971; 217: 177-183.
43. Tomihira M, Kawasaki E, Nakajima H et al. Intermittent and recurrent hepatomegaly due to glycogen storage in a patient with type 1 diabetes: genetic analysis of the liver glycogen phosphorylase gene (PYGL). Diabetes Res Clin Pract 2004; 65: 175-182.
44. EMA confirms recommendations to minimise ketoacidosis risk with SGLT2 inhibitors for diabetes. In.
45. Perkins BA, Cherney DZ, Partridge H et al. Sodium-glucose cotransporter 2 inhibition and glycemic control in type 1 diabetes: results of an 8-week openlabel proof-of-concept trial. Diabetes care 2014; 37: 1480-1483.
46. Sands AT, Zambrowicz BP, Rosenstock J et al. Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes. Diabetes care 2015; 38: 1181-1188.
47. St Hilaire R, Costello H. Prescriber beware: report of adverse effect of sodium-glucose cotransporter 2 inhibitor use in a patient with contraindication. The American journal of emergency medicine 2014.
48. Kuhadiya N, Mehta A, Ghanim H et al. The Combination of insulin, Liraglutide, and Dapagli ozin as Triple Therapy for Type 1 Diabetes. Diabetes 2015; 64: LB34.
49. Peters AL, Buschur EO, Buse JB et al. Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition. Diabetes care 2015; 38: 1687-1693.
50. Burr K, Nguyen A, Rasouli N. SAT 586-604-Diabetes Case Reports II Clinical. In: Endocrine Society Meeting. San Diego, California.
51. Chaudhury F. Diabetic ketoacidosis following SGLT2 inhibitor therapy in T2DM. In: American Association of Clinical Endocrinology Meeting. Nashville, TN.: 2015.
52. Hine J, Paterson H, Abrol E et al. SGLT inhibition and euglycaemic diabetic ketoacidosis. The lancet. Diabetes & endocrinology 2015; 3: 503-504.
53. Hayami T, Kato Y, Kamiya H et al. Case of ketoacidosis by a sodium-glucose cotransporter 2 inhibitor in a diabetic patient with a low-carbohydrate diet. Journal of diabetes investigation 2015; 6: 587-590.